Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Prepaid Assets (2016 - 2025)

Arrowhead Pharmaceuticals' Prepaid Assets history spans 16 years, with the latest figure at $16.1 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 179.91% year-over-year to $16.1 million; the TTM value through Dec 2025 reached $16.1 million, up 179.91%, while the annual FY2025 figure was $10.9 million, 14.64% up from the prior year.
  • Prepaid Assets reached $16.1 million in Q4 2025 per ARWR's latest filing, up from $10.9 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $23.8 million in Q1 2025 to a low of $1.8 million in Q1 2021.
  • Average Prepaid Assets over 5 years is $9.9 million, with a median of $7.8 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: soared 822.14% in 2022, then plummeted 80.04% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $2.8 million in 2021, then surged by 200.97% to $8.4 million in 2022, then dropped by 15.55% to $7.1 million in 2023, then dropped by 19.27% to $5.7 million in 2024, then soared by 179.91% to $16.1 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Prepaid Assets are $16.1 million (Q4 2025), $10.9 million (Q3 2025), and $23.7 million (Q2 2025).